These include semaglutide, exenatide, liraglutide, and dulaglutide
February 2025 A study published January 30, 2025, found that medications like Ozempic and Mounjaro, commonly used to treat diabetes and aid in weight loss, may be linked to rare eye conditions that can cause vision loss or even blindness
Bristol Myers Squibb Bristol Myers Squibb engages in exploring innovative peptide therapeutics and combination treatments
Pharmacotherapy should be considered for patients with BMI 30 kg/m or BMI 27 kg/m with weight-related comorbidities who have not achieved goals with lifestyle modification alone
[DOI] [PMC free article] [PubMed] 16.Sharma D, Verma S, Vaidya S, Kalia K, Tiwari V
I didnt have any rebound